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Abstract
Vulnerable atherosclerotic plaques are characterized by large necrotic cores caused by
impaired clearance of apoptotic cells (efferocytosis) in the artery wall. Targeted antibody
blockade of CD47 (CD47), an anti-efferocytosis protein, enhances efferocytosis and
reduces plaque area in mouse models of atherosclerosis. LDL receptor-related protein-1
(LRP1) is a pro-efferocytosis receptor whose deletion from macrophages accelerates
atherogenesis. We recently found that CD47 requires macrophage LRP1 to limit
atherosclerosis. Thus, we hypothesize that the enhanced efferocytosis caused by CD47
also requires macrophage LRP1. We conducted in vitro studies using wildtype (WT) and
LRP1-/- macrophages as efferocytes and either Jurkat lymphocyte cells or WT and LRP1/-

murine macrophages as apoptotic cell substrates (ACs). To stimulate efferocytosis,

violet fluorescent-labeled apoptotic cells were co-incubated with green fluorescentlabeled efferocytes in the presence of CD47 (10µg/mL) or IgG control. Phagocytic
index (PI) is determined using confocal microscopy and flow cytometry as the percent of
efferocytes with internalized ACs. In experiments using Jurkat cells as ACs, CD47
increased PI 2.4-fold and 2.0-fold in WT and LRP1 -/- efferocytes, respectively, compared
to IgG control. No differences in PI were observed between WT and LRP1 -/- efferocytes
treated with CD47 or IgG control. In experiments using WT and LRP1-/- macrophages
as ACs, we observed no differences in PI between WT and LRP1 -/- efferocytes.
Interestingly, the use of LRP1-/- macrophages as ACs reduced the PI of WT efferocytes
by 44.7% relative to WT macrophage ACs and independently of CD47. These data
suggest that the loss of LRP1 on ACs, not the efferocyte, impairs efferocytosis
independently of CD47 by rendering the dying cells a poor substrate for clearance.
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CD47 Blockade Enhances Macrophage Efferocytosis Via a Process Requiring LowDensity Lipoprotein Receptor-Related Protein 1
Introduction
Atherosclerosis is a progressive inflammatory disease of the arteries, the
underlying cause of myocardial infarction (MI) and cerebrovascular accident (CVA), the
leading causes of death worldwide (WHO, 2018). Atherosclerotic plaques develop
progressively throughout an individual’s lifetime and can become vulnerable to rupture.
A key feature of vulnerable plaques is the formation of a necrotic core (NC). The NC
contains cellular debris and lipids originating from apoptotic cells which have undergone
secondary necrosis as a result of their impaired removal through efferocytosis (Linton et
al., 2015; Tabas, 2016). By studying the pathogenesis and resolution of the necrotic core
via efferocytosis, novel treatments can be created to lower the mortality rate of
atherosclerotic sequelae MI and CVA.
In healthy individuals, the arteries are primarily composed of the endothelium
(intima), sub-endothelial region, a layer of smooth muscle cells (media), and adventitia
(Fig. 1). The endothelium is the inner-most layer and is composed of a single layer of
simple squamous endothelial cells connected by tight junctions to prevent leakage of
circulating blood from the lumen where blood flows (Saladin, 2012).
There are two common types of blood flow, laminar and turbulent flow. Laminar
flow occurs in regions where blood flows in a straight line, free of branching. In areas of
laminar flow, endothelial cells exhibit coaxial alignment and synthesize compounds
which promote endothelial health and atherosclerosis resistance. In contrast, areas of
curvature, branching, and bifurcation have turbulent flow, and endothelial cells present
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polymorphic structure and disordered alignment leading to a susceptibility to
atherosclerosis (Linton et al., 2015). These athero-susceptible regions also show an
increased inflammatory response (Linton et al., 2015).
Figure 1. General Anatomy of an Artery. A.
The lumen is the opening of the artery where
blood flows. B. The intima is a single layer of
endothelial cells. Immediately underneath it
is the sub-endothelial space where
atherosclerosis develops. C. The elastic
lamina can be present in both positions, as
shown, depending on the size of the artery.
They give the arteries elasticity to
compensate for the dynamic nature of blood
flow in the arteries. D. The media is a
multilayer region composed of smooth
muscle
cells.
It’s
contribution
to
atherosclerosis is significant, though it will
not be covered in this text. E. The externa
(adventitia) is a layer primarily composed of
collagen on the outermost portion of the
blood vessel.

A.
B.
C.
D.
C.
E.

Atherosclerosis is initiated (Fig. 2) by the deposition and retention of
apolipoprotein B (ApoB) containing lipoproteins (LDL), from circulation, into the
subendothelial region of athero-susceptible areas of the arteries. The ApoB component of
LDL interacts with proteoglycans in the subendothelial matrix and becomes trapped.
Trapped LDL can undergo modification by interactions with reactive oxygen species
(ROS) leading to the formation of oxidized LDL (ox-LDL). The LDL and ox-LDL incite
an inflammatory response by the overlying endothelium.
One common inflammatory response is the upregulation of nuclear transcription
factors in the nucleus of the endothelial cells which cause the presentation of monocyte
adherent proteins on the luminal side of the endothelium. Monocytes present in the blood
roll along the endothelium, attach to the adherent proteins, and migrate into the
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subendothelial space (Kasikara, Doran, Cai, & Tabas, 2018; Linton et al., 2015; Moore &
Tabas, 2011).
Monocytes differentiate into macrophages and begin the process of LDL and OxLDL uptake, and conversion to HDL (efflux) by way of reverse cholesterol transport.
Initially, the clearance of LDL is likely beneficial (Moore, Sheedy, & Fisher, 2013)
however, there is a net influx of LDL/Ox-LDL which overwhelms the efflux mechanism
leading to the formation of lipid-laden foam cell macrophages.
Foam cells are characterized by a decreased ability to migrate out of the subendothelial space, leading to an increased inflammatory response and advanced complex
plaques (Moore et al., 2013). Foam cells, with their decreased ability to emigrate out of

A.

B.

C.

D.

E.

Figure 2. Atherosclerosis progression. A. Initiation begins with LDL-cholesterol depositing
into the subendothelial region between the endothelium (intima) and smooth muscle cells
(media) of the artery wall. B. Activation of the endothelium leads to monocyte recruitment
into the subendothelial space where they differentiate into macrophages and begin
phagocytosing LDL. C. Macrophages uptake cholesterol faster than they can process it
through reverse cholesterol transport and become macrophage foam cells. D. Foam cells
undergo programmed cell death (apoptosis) and are not efficiently cleared through
efferocytosis. The apoptotic foam cells undergo secondary necrosis and contribute their
contents to the plaque forming a necrotic core. E. There is little negative feedback and the
cycle repeats resulting in the growth of the necrotic core. Eventually, the plaque ruptures
leading to the formation of a thrombus in the lumen. The thrombus cuts off blood flow
downstream causing infarction which leads to tissue death downstream of the thrombus.

the cell wall, undergo programmed cell death (apoptosis) likely as a result of endoplasmic
reticulum stress (Seimon & Tabas, 2009).
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In atherosclerosis, apoptosis is dysregulated, and cell death occurs at an
accelerated rate due to the highly toxic environment in advanced plaques (Linton et al.,
2015). Apoptosis is normally resolved through programmed cell removal, known as
efferocytosis (Elliott, Koster, & Murphy, 2017). In the early stages of atherosclerosis, the
rate of clearance appears to be conserved due to low the low levels of apoptotic cells
present in the plaque (Seimon & Tabas, 2009; Tabas, 2010). However, in advanced
plaques, the necrotic core (NC) shows a high level of macrophage debris and lipid
content, leading to the conclusion that post-apoptotic (necrotic) foam cells are a driving
force in the development of the NC and instability of advanced plaques. Post-apoptotic
necrosis involves leaky membranes and organelle swelling leading to complete cellular
death (Seimon & Tabas, 2009). Thus, necrotic foam cells contribute their lipid contents
and cellular debris to the NC.
Under normal conditions, the body can remove upwards of one-million apoptotic
cells per second (Kojima, Weissman, & Leeper, 2017). Efferocytosis is a highly
conserved and regulated process to prevent off-target removal of healthy tissue (Kojima
et al., 2017). However, in atherosclerosis, this process is dysregulated leading to an
accumulation of post-apoptotic cellular debris as mentioned above (Kojima et al., 2017).
Efferocytosis involves the engulfment (phagocytosis) of whole apoptotic cells by
either professional (macrophages) or non-professional (dendritic cells, smooth muscle
cells) efferocytes. Several molecules have been implicated in the balance of efferocytosis
signaling (Fig. 3). Efferocytosis signaling can be categorized into the, “don’t eat me,”
“find me,” and “eat me” stages.
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Healthy cells express anti-efferocytosis “don’t eat me” signals such as CD47, an
integrin-associated cell surface protein which prevents immune cells from marking
healthy cells for removal. CD47 interacts with the transmembrane protein SIRP found
on the surface of the engulfing cell, inhibiting efferocytosis (Gardai et al., 2005). CD47 is
overexpressed in malignant tumors, and anti-CD47 (CD47) antibodies have been shown
to have a positive effect on malignant tumor regression (Majeti et al., 2009). As a result,
CD47 became a subject of study in atherosclerosis where it has been shown to be
A.
Healthy
cell

Macrophage

Apoptosis
D.
B.

Efferocytosis
C.

Figure 3. Normal Efferocytosis and
Impaired Efferocytosis. A. A healthy
cell, shown in yellow, expresses the
anti-efferocytosis signal, CD47.
CD47 interacts with SIRP⍺ which
is present on the incoming
macrophage (green). B. When
the healthy cell undergoes
apoptosis (shown in orange),
CD47 is down regulated and proefferocytosis
signals
are
upregulated. From the top down.
CD36 interacts with oxidized
moieties of efferocytosis signals
such as ox-phosphatidylserine,
or ox-LDL. LRP1 interacts with a
phosphatidylserine/calreticulin
complex. MerTK interacts with
the efferocytosis signal Gas6. C.
The interaction between proefferocytosis signals and proefferocytosis receptors allows for
the phagocytosis (efferocytosis)
of the apoptotic cell. A key
difference
between
general
phagocytosis and efferocytosis is
that the apoptotic cell is engulfed
whole. D. In atherosclerotic
plaques,
CD47
remains
upregulated on the apoptotic cell.
This
interaction
prevents
efferocytosis and leads to
secondary necrosis of the
apoptotic cell.
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upregulated in atherosclerotic plaques. Furthermore, a CD47 antibody blockade has been
shown to prevent atherosclerosis via increased efferocytosis (Kojima et al., 2016).
Efferocytosis initiation occurs when an apoptotic cell expresses chemoattractant
“find me” ligands. In addition to recruiting both professional and non-professional
efferocytes, these ligands are also responsible for decreasing expression of a cell’s “don’t
eat me” signals and rapidly upregulating the expression of “eat me” signals (Tabas,
2010).
Pro-efferocytosis “eat me” signals are expressed on the surface of apoptotic cells.
Several pro-efferocytosis “eat me” signals and bridging molecules have been identified.
In one example, calreticulin, a chaperone protein, is upregulated on the surface of
apoptotic cells. Calreticulin forms a complex with phosphatidylserine on the surface of
the apoptotic cell. This complex interacts with the pro-efferocytosis receptor low-density
lipoprotein receptor-related protein 1 (LRP1), allowing phagocytosis of the apoptotic cell
(Kojima et al., 2017).
Pro-efferocytosis receptors are found on the surface of both professional and nonprofessional efferocytes. Several cell-surface “eat me” receptor proteins and have been
identified such as CD36, MerTK, and the subject of this study, LRP1 (Fadok, Warner,
Bratton, & Henson, 1998; Thorp, Cui, Schrijvers, Kuriakose, & Tabas, 2008; Yancey et
al., 2011). When activated, pro-efferocytosis receptors allow for engulfment of the
apoptotic cell by the efferocyte. Recently, it has been shown that the loss of macrophage
LRP1 accelerates atherosclerosis progression, leading to larger plaques, increased
necrotic core size, and decreased efferocytosis (Overton, Yancey, Major, Linton, &
Fazio, 2007; Yancey et al., 2010; Yancey et al., 2011).
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Based on these previous studies, Fazio lab conducted experiments to ascertain
what effect the loss LRP1, present on the efferocyte, had on efferocytosis in the presence
of a CD47 antibody blockade (CD47). They conducted in vivo experiments on atherosusceptible (ApoE-/-), and ApoE-/-/macrophage specific LRP1 (MLRP1-/-) double
knockout mice fed a high-fat diet for 12 weeks. Both groups of mice were treated with a
B.

D.

CD47
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0

E.
Necrotic Area
(x103  m2)

C.
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p=0.1119
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5
0

IgG CD47
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20
0

-/-

p = 0.1324

Spleen to Body Weight Ratio

CD47

IgG

Sectional Lesion Area
(x103  m2)

A.

IgG CD47

-/-

Fig 4. Macrophage LRP1 /ApoE double knockout mice were fed a high-fat (Western) diet
while receiving anti-CD47 blocking antibody (200g/injection) or IgG control every other day
for 12 weeks. (A) and (B) aortic sinus sections were stained with oil red-O lesion area
quantified. (C) Spleen weight to body weight ratio. (D) and (E) necrotic core area was
determined in aortic sinus sections using Mason’s Trichrome stain and acellular area
quantified. *P<0.05; ****P<0.0001. Figure courtesy of Paul Mueller, Ph.D.

CD47 blocking antibody or IgG control on alternating days for twelve weeks. Mice were
euthanized, and cross sections of the aortic sinus were removed. The lesion and necrotic
core areas of the aortic sinus were then measured and quantified. The results show that
the double knockout (ApoE-/-/ MLRP1-/-) mice had larger lesions and larger necrotic
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cores when compared to the ApoE -/- mice (Fig. 4 & 5). Spleen to body weight ratio was
measured as a way to verify the effects of CD47. Young erythrocytes express high
levels of CD47, and a CD47 blockade prevents efferocytosis of apoptotic erythrocytes.
CD47

B.

IgG

CD47

E.
Necrotic Area
(x103 m2)

D.
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200
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0

30

IgG CD47
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Spleen to Body Weight Ratio

IgG

Sectional Lesion Area
(x103 m2)

A.

20

****

15
10
5
0

IgG CD47

10

0

IgG CD47

-/-

Fig 5. ApoE mice were fed a high fat while receiving anti-CD47 blocking antibody
(200g/injection) or IgG control every other day for 12 weeks. (A) and (B) aortic sinus sections
were stained with oil red-O lesion area quantified. (C) Spleen weight to body weight ratio. (D)
and (E) necrotic core area was determined in aortic sinus sections using Mason’s Trichrome
stain and acellular area quantified. *P<0.05; ****P<0.0001. Figure courtesy of Paul Mueller,
Ph.D.

Apoptotic erythrocytes accumulate in the spleen. Therefore, mice receiving an CD47
treatment have a larger spleen ratio compared to the no-treatment group.
Because of these findings, we hypothesized that the enhanced efferocytosis
imparted by an CD47 blockade, requires macrophage LRP1. To test this hypothesis, we
conducted in vitro studies using J774, and WT or LRP1-/- macrophages as efferocytes.
Jurkat lymphocytes were used as apoptotic cell substrates (ACs). Additional experiments
involved testing LRP1-/- macrophages as substrates for efferocytosis, this involved in
vitro studies using either WT or LRP1 -/- macrophages as either efferocyte or ACs. Further
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experiments were also conducted to measure protein expression of select proefferocytosis receptors in WT and LRP1 -/- macrophages.
Methods
Cells
For in vitro assay development, we used murine derived J774 macrophages as
efferocytes and human-derived Jurkat T-lymphocytes as apoptotic substrate. Both cell
types were incubated in Corning T-75cm2 flasks at 37C. J774’s were cultured in 10%
FBS, 1% penicillin/streptomycin, Gibco 1X Dulbecco’s Modified Eagle Medium
(DMEM). Jurkat cells were incubated in 10% FBS, 1% penicillin/streptomycin, Gibco
1640 Rosewell Park Memorial Institute (RPMI) + GlutamaxTM media. Cells were
passaged at approximately 80-90% confluency.
For efferocytosis and substrate experiments peritoneal primary macrophages were
obtained from either WT or MLRP1-/- mice who had received thioglycolate injections
to the abdomen five days prior to cell extraction. Cell extraction was performed, and cells
were seeded directly into 12 or 24-well plates (1x106 cells/well) in 10% FBS, 1%
pen/strep, DMEM, and incubated at 37C. All experiments involving mice were carried
out according to and with approval from Oregon Health & Science University’s
Institutional Animal Care and Use Committee (IACUC).
Immunohistochemistry
Immunohistochemical fluorescent probes were used in order to perform confocal
and fluorescence-activated cell sorting for efferocytosis quantification. Macrophages
were labeled with InvitrogenTM Vybrant carboxyfluorescein diacetate, succinimidyl
ester (CFDA SE) green cell tracker. Macrophages assigned for confocal microscopy were
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incubated overnight in 12-well plates containing poly-L-lysine 12mm round coverslips.
The CFDA SE was reconstituted in 90L DMSO for a working solution of 10mM. Cells
were washed two times with pre-warmed 1X-PBS, then incubated in 1X PBS containing
5 M CFDA SE for 15 minutes at 37C. Cells were then washed two times with prewarmed 1X-PBS. DMEM containing 10% FBS/1% penicillin/streptomycin was replaced
in the wells and cells were incubated at 37C for 30 minutes.
Apoptotic cells were labeled with InvitrogenTM CellTrackerTM Violet BMQC
(2,3,6,7-tetrahydro-9- bromomethyl-1H,5H- quinolizino(9,1‐gh)coumarin), for
fluorescence-activated cell sorting, or InvitrogenTM CellTrackerTM Red CMTPX
(C42H40ClN3O4) cell dye, for confocal microscopy. Violet BMQC was reconstituted in
29.9L DMSO for a concentration of 10mM. Red CMTPX was reconstituted in 7.28L
of DMSO for a concentration 10mM. Jurkat cells were centrifuged at 1,100 rpm for 10
minutes. Media was removed and replaced with serum-free DMEM containing 5M
Violet BMQC, or Red CMTPX, and cells were incubated at 37C for 30 minutes. After
30 minutes, cells were centrifuged and washed in pre-warmed 1X-PBS with a cell count
performed at this step. Cells were centrifuged and resuspended in phenol-free/serum-free
DMEM. Jurkat cells were then seeded into 6-well plates at 3x106 cell/well.
Confocal Microscopy
Confocal microscopy was conducted using a Nikon A1R microscope.
Efferocytosis was quantified by manually counting cells in the open source software,
ImageJ. To determine phagocytic index (PI) the image was divided into grids and
portions of the grid were randomly selected. Then green macrophages and green
macrophages containing a red apoptotic cell were counted in the selected portions. If one
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macrophage was in contact with or contained multiple apoptotic cells; or if multiple
macrophages were in contact with one apoptotic cell, then each was counted as a separate
efferocytosis event (Fig. 7 in results section).
Fluorescence Activated Cell Sorting – Flow Cytometry
Flow cytometry was conducted on the BD Biosciences LSR II flow cytometer.
Green fluorescence was measured on the 488nm wavelength, and violet fluorescence was
measured on the 405nm wavelength. Instrument software measured the forward scatter
(FSC-A) distinguishing the size of the cells, and side scatter (SSC-A) which measures the
granularity or complexity of the cells. Because macrophages are considerably larger than
the apoptotic lymphocytes, this allowed us to easily distinguish between cell populations
based on size (Fig. 6).
Cell populations were then “gated” according to their fluorescent intensity by
utilizing green only CFDA-SE (488nm), violet only BMQC (405nm), and unlabeled cell
populations. This allowed us to divide the scatter plot in the software into four quadrants,
with green only cells in quadrant three, violet only cells in quadrant one, and unlabeled
population in quadrant four.
To determine phagocytic index (PI), that is, the percent of total macrophages
containing an apoptotic body, quadrant one (violet only) and quadrant four (unlabeled)
were excluded from the measurements. Thus, the only cells counted were in the green
population. Green labeled cells containing a violet signal (double positive) counted as
efferocytosis and were present in quadrant two.
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Unlabeled

Lymphocytes

Violet

SSC-A

Macrophages

FSC-A
C.

Green
D.

Violet Only

Violet

Violet

Green Only

Green

Green

Figure 6. A. Side Scatter (SSC-A) shown on the y-axis measures the complexity of a cell
based on its granularity and shape. Forward Scatter (FSC-A) shown on the x-axis and
measures the size of the cell. B. Unlabeled cell populations present in quadrant 4 (Q4) and
gated accordingly to exclude this population from the cell count. C. Green-only cells,
measured in the 488nm wavelength, present in quadrant 3. D. Violet only cells, measured in
the 405nm wavelength appear in quadrant 1. Phagocytic index was measured as the percent
of total macrophages (green) containing an apoptotic body and appeared in quadrant two as
a double positive signal (green and violet).

Western Blot
MerTK (110 kDa) expression was measured in WT and LRP1-/- macrophages to
determine if the loss of LRP1 upregulated other pro-efferocytosis receptors. Protein was
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extracted from cells, and Lowry assay was conducted to determine protein concentration.
Protein mixture was prepared at 30g in Thermo-Fisher Scientific invitrogen NuPageTM
LDS Sample Buffer, Thermo-Fisher Scientific invitrogen NuPage TM Sample Reducing
Agent, and deionized water. Protein samples (30g) were loaded into Thermo-Fisher
Scientific Invitrogen NuPageTM 4-12% Bis-Tris Gel (1.0 mm x 10 well). Electrophoresis
was started at 100-volts for approximately 10 minutes, then at 120-volts for one and a
half hours. The gel was transferred on ice on to GE Healthcare Life Sciences Amersham
Protran Premium 0.45m nitrocellulose blotting membrane for two and a half hours at
28-volts. The blotting membrane was then placed in 5ml LI-COR Odyssey blocking
buffer (TBS) for one hour.
After blocking, the blocking buffer was removed, and R&D systems goat antimouse MerTK primary antibody (1:1000), and abcam rabbit anti-mouse vinculin (124
kDa) primary antibody (1:2500), in 5mL of Odyssey blocking buffer were added to the
membrane. The membrane was then placed on a rocker overnight at 4C.
The next day, the primary antibody solution was removed, and the membrane was
washed three times with Tris-buffered saline containing polysorbate 20 (TBST) for 10
minutes each time. After the washes, LI-COR secondary antibodies were added in 5ml
Odyssey blocking buffer. We used donkey anti-goat 800CW for MerTK to be read on
the green channel (800nm). For vinculin, we used goat anti-rabbit 680RD to be read on
the red channel (700nm). Fluorescence intensity was measured using the LI-COR
Odyssey CLx blot imager, and LI-COR ImageStudioTM software.
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Experiments
Experiments took place over ten weeks during the summer of 2016 at the Knight
Cardiovascular Institute – Center for Preventive Cardiology under the supervision of
Sergio Fazio MD/Ph.D. (Director of the Center for Preventive Cardiology), and Paul
Mueller Ph.D.
Prior to the induction of apoptosis, well conditions were assigned, and Jurkat cells
were incubated with either CD47 antibody (CD47) or IgG at a concentration of
10g/mL, during induction of apoptosis. All experiments contained a no-treatment (NT)
control. For anti-CD47/LRP1 efferocytosis experiments, apoptosis was induced in Jurkat
cells in 6-well plates exposed to long wavelength ultraviolet light for 30 minutes. Plates
were placed directly underneath light source at a distance of 10 cm. Apoptosis induction
for LRP1 substrate experiments utilized staurosporine (1M) protein kinase inhibitor in
serum-free DMEM.
For CD47/LRP1 versus WT experiments, efferocytosis was stimulated by coincubating apoptotic violet labeled Jurkat cells (either NT, CD47, or IgG) with J774,
WT, or LRP1-/- green labeled macrophages. Macrophages were washed two times with
pre-warmed 1X PBS, and 1x106 Jurkat cells were placed directly into the wells, in serumfree DMEM, with the macrophages according to assigned conditions. Cells were coincubated for 2 hours. After two hours wells were washed two times with pre-warmed
PBS and fixed with 4% paraformaldehyde (PFA) for 15 minutes.
After fixing, wells assigned for FACS were placed in polystyrene round-bottom
tubes and taken for flow cytometry either the same or next day. For wells containing
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coverslips, for confocal microscopy, the coverslips were carefully removed and mounted
on microscope slides with 5L 4′,6-diamidino-2-phenylindole (DAPI) DNA stain.
Data Analysis
Statistical analysis was conducted using GraphPad Prism 6 statistical analysis
software.
Results
Confocal Microscopy Produces High Variability

WT

-/-

LRP1

Basal Efferocytosis

⍺CD47

IgG

Figure 7. Confocal Microscopy was used to quantify phagocytic Index. Green labeled
macrophages were co-incubated with red labeled apoptotic cells then imaged on a Nikon
A1R Confocal Microscope. An efferocytosis event was counted when a macrophage
contained or was in contact with an apoptotic cell, indicated by the yellow arrows. If a
macrophage contained multiple apoptotic cells, or multiple macrophages were in contact
with one apoptotic cell, each was counted as a separate event.

Phagocytosis Index
(% Macrophages with AB)

Confocal Microscopy
50
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40
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For confocal microscopy, primary macrophages (WT or LRP1-/-) were seeded
onto coverslips, labeled green, and co-incubated with violet labeled apoptotic Jurkat cells.
Prior to co-incubation, and during apoptosis induction, the Jurkat cells received either the
CD47 blocking antibody, IgG control or no treatment. The cells were imaged and
counted as outlined in the methods section. The macrophages were extracted from three
mice for each genotype and mixed. The cells were then seeded in triplicate into the wells.
That is three slides per condition (n=3). When imaged, the slides showed a high degree of
confluency. Therefore, a grid was overlaid on the image in ImageJ, and arbitrary grid
sections were quantified. Five grid sections were selected, and the percent efferocytosis
from each section were averaged. As will be discussed, there were imaging issues with
the WT slides. This only allowed for quantification of n=1 for basal efferocytosis and
n=2 for IgG and CD47 for the WT group. For the LRP1-/- slides n=3 for all groups.
Basal efferocytosis produced a high degree of variability in the LRP1 -/- genotype.
Two slides had values of 35% and 31% phagocytic index (PI) respectively, while one had
13% PI. Due to the issues with the WT slides only one was quantified for the basal
condition yielding 31% PI. For the IgG group, the WT slides (n=2) had a PI of 33% and
19% respectively. The IgG LRP1 -/- group (n=3) had 20%, 27%, and 21% PI. For the
CD47 condition, WT (n=2) yielded 33% and 19% PI. The CD47 LRP1-/- group yielded
24%, 41%, and 18% PI. Due to the high variability of the results, no statistical tests were
performed on these results.
Fluorescence Activated Cell Sorting (FACS)
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FACS experiments were conducted concurrently with confocal microscopy experiments
as outlined in the methods section. WT and LRP1 -/- primary macrophages were seeded in
triplicate (n=3) into wells and labeled green. Violet labeled Jurkat cells were exposed to
IgG, CD47, or no treatment, while exposed to UV light to induce apoptosis.
Statistical analysis was conducted on GraphPad Prism 6 using a two-way
ANOVA with Sidak’s multiple comparisons test. The results show that there is no
difference in phagocytic index between WT and LRP1-/- genotypes for any of the
treatment groups (p <0.01). WT and LRP1-/- yielded 7.80% and 6.52% PI respectively. It
is worth noting that the phagocytic index observed in these experiments is significantly
lower than those observed in previous studies, discussed below.
Western Blot – MerTK
-/-
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Ladd
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MerTK Expression
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Protein expression of another pro-efferocytosis receptor, MerTK, was analyzed
via Western blot to ascertain if other pro-efferocytosis receptors were upregulated and
explain the results which were observed in the FACS results. This analysis was
conducted on WT or LRP1-/- primary macrophages (MLRP-/-) that were exposed to
either a vehicle (Serum-Free DMEM) or IgG control.
Macrophages from three mice were collected for each genotype and divided into
four replicates (n=4), and protein expression was quantified. A Mann-Whitney nonparametric test was conducted using GraphPad Prism 6. The results show a 1.46-fold
increase in MerTK expression in the LRP1-/- group compared to the WT (p =0.029).
Wild Type vs. LRP1 Substrate Experiments

LRP1-/- (KO) vs WT

WT vs LRP1-/- efferocytosis experiments were conducted in order to gain insight
into LRP1’s effect on a cell’s ability to be eaten. Primary macrophages from either WT or
LRP1-/- (KO) macrophages were collected and seeded into well plates. Four experimental
conditions were selected. WT phagocytosing WT or LRP1-/-, and LRP1-/- phagocytosing
WT or LRP1-/-. Efferocyte were labeled with a green fluorescent probe and ACs were
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labeled with a violet probe, as per previous experiments. For this experiment, the method
of inducing apoptosis was changed to staurosporine, discussed below. To determine
phagocytic index, FACS was performed.
A Kruskal-Wallis non-parametric one-way ANOVA, with Dunn’s multiple
comparison test, was conducted using GraphPad Prism 6. The results show a significant
decrease (22%, p <0.0001) in phagocytic index when a WT macrophage is phagocytosing
an LRP1-/- knockout ACs when compared to a WT phagocytosing a WT ACs.
Discussion
First, it is important to discuss the results for confocal microscopy. As the data
shows, there was a high degree of variability when we used this method. This variability
was consistent throughout assay development and multiple experimental trials.
Variability may be due to the small sample size. During the imaging process, some of the
coverslips did not fluoresce and thus, could not be quantified. Despite this, the levels of
variability have not been seen by other labs using a similar technique. However, due to
our results, it was determined that confocal microscopy is not an effective assay to
determine phagocytic index for efferocytosis in our model.
The results show that an LRP1 knockout does not affect efferocytosis given a
CD47 blockade in our model. Therefore, we began to investigate factors which may
explain our observations. First, we conducted Western blot analysis of another common
pro-efferocytosis receptor, MerTK. Our results show that MerTK was upregulated
approximately one and a half fold in the LRP1 knockout macrophages compared to the
wild type and standardized to our loading control vinculin. Additionally, recent
proteomics data generated in our lab shows that another pro-efferocytosis receptor,
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CD36, is highly upregulated in LRP1 knockout macrophages compared to the wild type.
Future studies will be conducted to determine the effect that these and other proefferocytosis factors have on efferocytosis.
The results from the FACS experiments also yielded a significantly lower
phagocytic index than those established by other groups. This was thought to be due to
the method of apoptosis induction, UV light. After these results, the method of apoptosis
induction was changed to a chemical method, staurosporine. Changing the method of
apoptosis induction brought the phagocytic index back in line with literature values as
observed in the substrate experiment results.
We also conducted an experiment using WT or LRP1-/- macrophages as either
apoptotic cell substrate (ACs) or efferocyte. This was done to determine the effect that
LRP1 had on a cells ability to be eaten. As the results indicate, an apoptotic cell with
LRP1 knocked out, results in a significantly lower phagocytic index when being
phagocytosed by a macrophage which expresses LRP1. Because of these results, we plan
to analyze a biological process known as autophagy.
As mentioned above, LRP1 is a multi-ligand receptor which plays a role in a wide
range of biological processes. LRP1 has been implicated as a key receptor in autophagy
(Grosso et al., 2019). Autophagy is the process by which a cell catabolizes and packages
unnecessary cellular components (Glick, Barth, & Macleod, 2010). Links have been
established between autophagy and apoptosis (Thorburn, 2008). Therefore, if LRP1 is not
expressed on an apoptotic cell, this disrupts efficient packaging of the apoptotic cells’
cellular components. The incoming efferocyte would have increased difficulty in
phagocytosing the apoptotic cell.
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Conclusion
The pro-efferocytosis receptor LRP1 is necessary for the athero-protective effect
of an anti-CD47 antibody blockade in vivo. However, an LRP1 knockout with a CD47
blockade in vitro does not show impaired efferocytosis compared to the wild type in our
model. Our subsequent protein expression analysis shows that this may be due to an
increase in the expression of other pro-efferocytosis receptors. However, a decrease in
efferocytosis is still seen in vivo. This decrease may be due to LRP1’s role in autophagic
flux, as discussed above. Therefore, we plan to conduct experiments that repeat the WT
versus LRP1-/- substrate experiments in the presence of CD47 and continue to measure
the expression of other pro-efferocytosis receptors in an effort to better understand the
mechanisms underlying the impaired efferocytosis seen in atherosclerosis.
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